PROTAC SGK3 degrader-1 is primarily utilized in biomedical research to target and degrade serum and glucocorticoid-regulated kinase 3 (SGK3) proteins. This application is crucial in studying the role of SGK3 in various cellular processes, particularly in cancer research, where SGK3 is often implicated in tumor growth and survival. By inducing the degradation of SGK3, researchers can better understand its function and explore its potential as a therapeutic target in diseases such as breast cancer and other malignancies. Additionally, this compound aids in the development of targeted protein degradation strategies, offering insights into novel treatment approaches for conditions driven by aberrant protein activity.